617 is the total number of securities Eventide Asset Management has owned. The longest Eventide Asset Management has owned a single stock is 39 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
LOW | LOWES COS INC | 39 | 39 | 1.30% | 2.13% | 3.22% | Q4 2013 | Q2 2023 | 39 |
PANW | PALO ALTO NETWORKS INC | 39 | 39 | 0.48% | 1.77% | 3.63% | Q4 2013 | Q2 2023 | 39 |
ASML | ASML HOLDINGS NV | 39 | 39 | 0.56% | 1.37% | 1.90% | Q4 2013 | Q2 2023 | 39 |
NBIX | NEUROCRINE BIOSCIENCES... | 39 | 39 | 0.11% | 0.48% | 1.07% | Q4 2013 | Q2 2023 | 39 |
RGEN | REPLIGEN CORP | 39 | 39 | 0.11% | 0.29% | 0.45% | Q4 2013 | Q2 2023 | 39 |
VCYT | VERACYTE INC | 37 | 37 | 0.18% | 0.69% | 1.46% | Q2 2014 | Q2 2023 | 37 |
LRCX | LAM RESEARCH CORP | 34 | 34 | 0.82% | 1.82% | 3.44% | Q1 2015 | Q2 2023 | 34 |
XPO | XPO LOGISTICS INC | 34 | 34 | 0.00% | 1.58% | 3.76% | Q4 2014 | Q1 2023 | 34 |
MGA | MAGNA INTL INC | 33 | 33 | 0.71% | 1.50% | 2.49% | Q4 2013 | Q4 2021 | 33 |
CCI | CROWN CASTLE INTL CORP... | 33 | 33 | 0.58% | 1.44% | 3.26% | Q1 2015 | Q1 2023 | 33 |
COLL | COLLEGIUM PHARMACEUTIC... | 33 | 33 | 0.63% | 1.30% | 2.64% | Q2 2015 | Q2 2023 | 33 |
NEP | NEXTERA ENERGY PARTNER... | 32 | 32 | 0.00% | 1.49% | 2.17% | Q3 2015 | Q2 2023 | 32 |
BPMC | BLUEPRINT MEDICINES CORP | 32 | 32 | 0.13% | 0.66% | 1.32% | Q3 2015 | Q2 2023 | 32 |
BEP | BROOKFIELD RENEWABLE P... | 32 | 32 | 0.00% | 0.42% | 1.26% | Q3 2015 | Q2 2023 | 32 |
HASI | HANNON ARMSTRONG SUST ... | 31 | 31 | 0.08% | 0.65% | 1.00% | Q4 2015 | Q2 2023 | 31 |
XNCR | XENCOR INC | 29 | 29 | 0.21% | 0.33% | 0.59% | Q1 2015 | Q1 2022 | 29 |
TSM | TAIWAN SEMICONDUCTOR M... | 17 | 12 | 0.00% | 0.20% | 0.79% | Q3 2015 | Q2 2023 | 29 |
IPHI | INPHI CORP | 28 | 28 | 0.75% | 1.22% | 2.32% | Q4 2013 | Q3 2020 | 28 |
ASND | ASCENDIS PHARMA A/S | 27 | 27 | 0.30% | 3.49% | 6.88% | Q4 2016 | Q2 2023 | 27 |
WCN | WASTE CONNECTIONS INC | 27 | 27 | 0.90% | 1.72% | 2.44% | Q4 2016 | Q2 2023 | 27 |
SRPT | SAREPTA THERAPEUTICS INC | 15 | 2 | 0.24% | 1.71% | 5.19% | Q4 2013 | Q2 2023 | 27 |
GWPH | GW PHARMACEUTICALS PLC | 27 | 27 | 0.18% | 0.51% | 1.28% | Q2 2014 | Q4 2020 | 27 |
STML | STEMLINE THERAPEUTICS INC | 26 | 26 | 0.22% | 0.77% | 1.49% | Q4 2013 | Q1 2020 | 26 |
TTD | THE TRADE DESK INC | 25 | 25 | 0.84% | 2.22% | 3.34% | Q2 2017 | Q2 2023 | 25 |
LEA | LEAR CORP | 25 | 25 | 0.71% | 1.87% | 3.25% | Q4 2013 | Q4 2019 | 25 |
EXAS | EXACT SCIENCES CORP | 25 | 25 | 0.22% | 1.63% | 3.54% | Q2 2017 | Q2 2023 | 25 |
HUBS | HUBSPOT INC | 25 | 25 | 0.85% | 1.53% | 2.12% | Q2 2017 | Q2 2023 | 25 |
XLRN | ACCELERON PHARMA INC | 20 | 5 | 0.13% | 0.58% | 1.45% | Q2 2014 | Q1 2021 | 25 |
FIVN | FIVE9 INC | 24 | 24 | 0.75% | 2.01% | 3.13% | Q3 2017 | Q2 2023 | 24 |
SPLK | SPLUNK INC | 24 | 24 | 0.67% | 1.75% | 2.62% | Q4 2014 | Q3 2020 | 24 |
KAR | KAR AUCTION SVCS INC | 24 | 24 | 0.46% | 1.62% | 2.60% | Q4 2013 | Q3 2019 | 24 |
STKL | SUNOPTA INC | 24 | 24 | 0.25% | 1.26% | 2.47% | Q4 2013 | Q3 2019 | 24 |
MIC | MACQUARIE INFRASTRUCTU... | 23 | 23 | 0.36% | 2.43% | 3.85% | Q4 2013 | Q2 2019 | 23 |
BLUE | BLUEBIRD BIO INC | 23 | 23 | 0.14% | 2.02% | 3.90% | Q4 2013 | Q2 2019 | 23 |
SAGE | SAGE THERAPEUTICS INC | 23 | 23 | 0.15% | 1.36% | 4.41% | Q3 2014 | Q1 2020 | 23 |
APTV | APTIV PLC | 23 | 23 | 0.70% | 1.01% | 1.48% | Q4 2017 | Q2 2023 | 23 |
BMRN | BIOMARIN PHARMACEUTICA... | 20 | 3 | 0.22% | 0.36% | 0.49% | Q4 2013 | Q2 2023 | 23 |
ROP | ROPER TECHNOLOGIES INC | 22 | 22 | 0.78% | 1.90% | 2.52% | Q1 2018 | Q2 2023 | 22 |
WBC | WABCO HLDGS INC | 22 | 22 | 0.61% | 1.71% | 2.36% | Q4 2013 | Q1 2019 | 22 |
ARGX | ARGENX SE | 22 | 22 | 0.34% | 1.34% | 2.59% | Q1 2018 | Q2 2023 | 22 |
MGNX | MACROGENICS INC | 20 | 2 | 0.12% | 0.56% | 1.32% | Q4 2013 | Q2 2019 | 22 |
KALV | KALVISTA PHARMACEUTICA... | 20 | 2 | 0.02% | 0.41% | 1.01% | Q1 2017 | Q4 2022 | 22 |
RARE | ULTRAGENYX PHARMACEUTI... | 18 | 4 | 0.21% | 0.33% | 0.59% | Q2 2014 | Q2 2023 | 22 |
MTD | METTLER TOLEDO INTERNA... | 21 | 21 | 0.65% | 2.02% | 3.70% | Q2 2018 | Q2 2023 | 21 |
W | WAYFAIR INC | 21 | 21 | 0.80% | 1.93% | 3.28% | Q4 2016 | Q4 2021 | 21 |
BHVN | BIOHAVEN PHARMACTL HLD... | 21 | 21 | 0.08% | 1.68% | 3.52% | Q2 2017 | Q2 2022 | 21 |
PLD | PROLOGIS INC. | 21 | 21 | 0.02% | 0.17% | 0.50% | Q2 2018 | Q2 2023 | 21 |
ABBV | ABBVIE INC | 20 | 20 | 0.01% | 2.39% | 3.42% | Q4 2013 | Q3 2018 | 20 |
AGIO | AGIOS PHARMACEUTICALS INC | 20 | 20 | 0.21% | 1.34% | 3.70% | Q4 2013 | Q3 2018 | 20 |
PFPT | PROOFPOINT INC | 20 | 20 | 0.51% | 1.14% | 1.90% | Q1 2015 | Q4 2019 | 20 |
EXR | EXTRA SPACE STORAGE INC | 20 | 20 | 0.26% | 0.73% | 2.42% | Q1 2015 | Q4 2019 | 20 |
GLPG | GALAPAGOS NV | 20 | 20 | 0.12% | 0.29% | 0.87% | Q1 2016 | Q4 2020 | 20 |
ACAD | ACADIA PHARMACEUTICALS... | 19 | 19 | 0.07% | 0.74% | 1.47% | Q4 2013 | Q2 2018 | 19 |
SUPN | SUPERNUS PHARMACEUTICA... | 19 | 19 | 0.23% | 0.40% | 0.77% | Q1 2014 | Q3 2018 | 19 |
CERN | CERNER CORP | 19 | 19 | 0.24% | 0.34% | 0.45% | Q1 2014 | Q3 2018 | 19 |
ARE | ALEXANDRIA REAL ESTATE... | 19 | 19 | 0.04% | 0.08% | 0.12% | Q2 2018 | Q4 2022 | 19 |
CELG | CELGENE CORP | 18 | 18 | 0.39% | 2.59% | 4.26% | Q2 2014 | Q3 2018 | 18 |
STLD | STEEL DYNAMICS INC | 18 | 18 | 0.69% | 1.61% | 2.24% | Q1 2015 | Q2 2019 | 18 |
TSLA | TESLA MTRS INC | 18 | 18 | 0.37% | 0.88% | 1.60% | Q4 2013 | Q1 2018 | 18 |
AY | ATLANTICA YIELD PLC | 18 | 18 | 0.41% | 0.80% | 1.28% | Q2 2016 | Q3 2020 | 18 |
ATHN | ATHENAHEALTH INC | 18 | 18 | 0.10% | 0.59% | 1.70% | Q4 2013 | Q1 2018 | 18 |
GBT | GLOBAL BLOOD THERAPEUT... | 9 | 9 | 0.04% | 0.49% | 1.20% | Q3 2015 | Q3 2020 | 18 |
QURE | UNIQURE NV | 10 | 8 | 0.04% | 0.49% | 1.18% | Q2 2014 | Q2 2020 | 18 |
EPIX | ESSA PHARMA INC | 18 | 18 | 0.04% | 0.31% | 1.04% | Q2 2018 | Q3 2022 | 18 |
TWLO | TWILIO INC | 12 | 5 | 0.58% | 1.84% | 3.68% | Q1 2017 | Q3 2021 | 17 |
IDXX | IDEXX LABS INC | 17 | 17 | 0.76% | 1.72% | 2.42% | Q2 2019 | Q2 2023 | 17 |
FPRX | FIVE PRIME THERAPEUTIC... | 17 | 17 | 0.08% | 1.70% | 3.25% | Q1 2014 | Q1 2018 | 17 |
ODFL | OLD DOMINION FREIGHT L... | 16 | 1 | 0.06% | 1.61% | 2.78% | Q3 2016 | Q2 2023 | 17 |
KRTX | KARUNA THERAPEUTICS INC | 17 | 17 | 0.16% | 1.38% | 2.30% | Q2 2019 | Q2 2023 | 17 |
SGEN | SEATTLE GENETICS INC | 14 | 3 | 0.34% | 1.28% | 2.76% | Q2 2015 | Q3 2020 | 17 |
PEGI | PATTERN ENERGY GROUP INC | 17 | 17 | 0.00% | 0.91% | 1.32% | Q3 2015 | Q3 2019 | 17 |
MRTX | MIRATI THERAPEUTICS INC | 17 | 17 | 0.16% | 0.52% | 1.09% | Q2 2019 | Q2 2023 | 17 |
STRO | SUTRO BIOPHARMA INC | 17 | 17 | 0.16% | 0.47% | 0.80% | Q3 2018 | Q3 2022 | 17 |
ISRG | INTUITIVE SURGICAL INC | 17 | 17 | 0.27% | 0.35% | 0.45% | Q2 2019 | Q2 2023 | 17 |
XENE | XENON PHARMACEUTICALS INC | 12 | 5 | 0.12% | 0.34% | 0.50% | Q3 2018 | Q2 2023 | 17 |
NTUS | NATUS MEDICAL INC DEL | 17 | 17 | 0.15% | 0.22% | 0.36% | Q4 2013 | Q4 2017 | 17 |
ABB | ABB LTD | 17 | 17 | 0.00% | 0.06% | 0.11% | Q3 2015 | Q3 2019 | 17 |
ETN | EATON CORP PLC | 17 | 17 | 0.00% | 0.04% | 0.08% | Q3 2015 | Q3 2019 | 17 |
ERIC | ERICSSON | 17 | 17 | 0.01% | 0.03% | 0.08% | Q3 2015 | Q3 2019 | 17 |
POOL | POOL CORPORATION | 16 | 16 | 1.11% | 1.51% | 1.86% | Q3 2019 | Q2 2023 | 16 |
LOXO | LOXO ONCOLOGY INC | 16 | 16 | 0.11% | 1.21% | 2.65% | Q1 2015 | Q4 2018 | 16 |
LII | LENNOX INTL INC | 16 | 16 | 0.37% | 0.98% | 1.61% | Q4 2017 | Q3 2021 | 16 |
VRTX | VERTEX PHARMACEUTICALS... | 14 | 2 | 0.15% | 0.79% | 2.22% | Q4 2015 | Q2 2020 | 16 |
DDOG | DATADOG INC | 16 | 16 | 0.32% | 0.73% | 1.18% | Q3 2019 | Q2 2023 | 16 |
TTPH | TETRAPHASE PHARMACEUTI... | 9 | 7 | 0.07% | 0.42% | 1.26% | Q4 2013 | Q4 2017 | 16 |
PRTA | PROTHENA CORP PLC | 11 | 1 | 0.06% | 0.35% | 0.52% | Q1 2014 | Q2 2023 | 16 |
ATRC | ATRICURE INC | 16 | 16 | 0.16% | 0.26% | 0.42% | Q4 2013 | Q3 2017 | 16 |
IEX | IDEX CORP | 16 | 16 | 0.02% | 0.14% | 0.31% | Q3 2019 | Q2 2023 | 16 |
LPT | LIBERTY PPTY TR | 16 | 16 | 0.00% | 0.02% | 0.03% | Q3 2015 | Q2 2019 | 16 |
CTAS | CINTAS CORP | 9 | 6 | 0.37% | 1.22% | 2.26% | Q4 2018 | Q3 2022 | 15 |
DHI | D R HORTON INC | 15 | 15 | 0.03% | 1.07% | 1.48% | Q4 2019 | Q2 2023 | 15 |
TREX | TREX CO INC | 15 | 15 | 0.74% | 1.05% | 1.71% | Q4 2019 | Q2 2023 | 15 |
VMC | VULCAN MATLS CO | 15 | 15 | 0.45% | 0.90% | 1.59% | Q1 2017 | Q3 2020 | 15 |
NOVT | NOVANTA INC | 15 | 15 | 0.29% | 0.54% | 0.73% | Q4 2019 | Q2 2023 | 15 |
CGNX | COGNEX CORP | 9 | 6 | 0.33% | 0.48% | 0.81% | Q2 2014 | Q2 2022 | 15 |
CWEN | CLEARWAY ENERGY INC | 12 | 3 | 0.00% | 0.47% | 0.88% | Q3 2018 | Q2 2023 | 15 |
ALNY | ALNYLAM PHARMACEUTICAL... | 15 | 15 | 0.20% | 0.36% | 0.60% | Q1 2015 | Q3 2018 | 15 |
TSRO | TESARO INC | 15 | 15 | 0.05% | 0.32% | 0.57% | Q4 2014 | Q2 2018 | 15 |
KLAC | KLA CORPORATION | 15 | 15 | 0.03% | 0.24% | 0.50% | Q4 2019 | Q2 2023 | 15 |
ETTX | ENTASIS THERAPEUTICS H... | 15 | 15 | 0.02% | 0.09% | 0.30% | Q3 2018 | Q1 2022 | 15 |
BDN | BRANDYWINE RLTY TR | 15 | 15 | 0.01% | 0.06% | 0.08% | Q3 2015 | Q1 2019 | 15 |
LXP | LEXINGTON REALTY TRUST | 15 | 15 | 0.00% | 0.02% | 0.03% | Q3 2015 | Q1 2019 | 15 |
CRWD | CROWDSTRIKE HLDGS INC | 14 | 14 | 1.23% | 2.11% | 3.26% | Q1 2020 | Q2 2023 | 14 |
AIMT | AIMMUNE THERAPEUTICS INC | 14 | 14 | 0.45% | 1.76% | 2.91% | Q1 2017 | Q2 2020 | 14 |
TT | TRANE TECHNOLOGIES PLC | 14 | 14 | 0.05% | 1.71% | 2.66% | Q1 2020 | Q2 2023 | 14 |
IDTI | INTEGRATED DEVICE TECH... | 14 | 14 | 1.09% | 1.31% | 1.64% | Q1 2015 | Q2 2018 | 14 |
BWA | BORGWARNER INC | 13 | 1 | 0.03% | 1.07% | 1.94% | Q4 2013 | Q4 2019 | 14 |
AYR | AIRCASTLE LTD | 14 | 14 | 0.45% | 0.78% | 1.90% | Q4 2013 | Q1 2017 | 14 |
VRSK | VERISK ANALYTICS INC | 14 | 14 | 0.23% | 0.72% | 1.34% | Q1 2020 | Q2 2023 | 14 |
RCKT | ROCKET PHARMACEUTICALS... | 11 | 3 | 0.18% | 0.47% | 0.91% | Q1 2018 | Q2 2023 | 14 |
MDB | MONGODB INC | 13 | 1 | 0.00% | 0.47% | 1.13% | Q3 2019 | Q1 2023 | 14 |
DBVT | DBV TECHNOLOGIES S A | 14 | 14 | 0.14% | 0.38% | 0.57% | Q1 2015 | Q2 2018 | 14 |
FRC | FIRST REP BK SAN FRANC... | 14 | 14 | 0.03% | 0.20% | 0.39% | Q3 2019 | Q4 2022 | 14 |
FENC | FENNEC PHARMACEUTICALS... | 14 | 14 | 0.09% | 0.19% | 0.42% | Q4 2017 | Q1 2021 | 14 |
DRNA | DICERNA PHARMACEUTICAL... | 14 | 14 | 0.07% | 0.14% | 0.26% | Q2 2014 | Q3 2017 | 14 |
SHW | SHERWIN WILLIAMS CO | 14 | 14 | 0.03% | 0.12% | 0.41% | Q1 2020 | Q2 2023 | 14 |
JCI | JOHNSON CTLS INTL PLC | 14 | 14 | 0.02% | 0.08% | 0.11% | Q3 2016 | Q4 2019 | 14 |
BG | BUNGE LIMITED | 14 | 14 | 0.01% | 0.05% | 0.08% | Q1 2016 | Q2 2019 | 14 |
WELL | WELLTOWER INC | 13 | 1 | 0.01% | 0.02% | 0.05% | Q4 2015 | Q3 2019 | 14 |
WAB | WABTEC CORP | 13 | 13 | 0.86% | 1.59% | 1.93% | Q4 2013 | Q4 2016 | 13 |
CRUS | CIRRUS LOGIC INC | 13 | 13 | 0.52% | 1.06% | 1.84% | Q4 2015 | Q4 2018 | 13 |
MYOV | MYOVANT SCIENCES LTD | 13 | 13 | 0.20% | 1.02% | 2.06% | Q1 2017 | Q1 2020 | 13 |
NVAX | NOVAVAX INC | 13 | 13 | 0.12% | 0.99% | 2.03% | Q4 2013 | Q4 2016 | 13 |
ENTG | ENTEGRIS INC | 13 | 13 | 0.02% | 0.89% | 1.70% | Q2 2020 | Q2 2023 | 13 |
ZNTL | ZENTALIS PHARMACEUTICA... | 13 | 13 | 0.30% | 0.86% | 3.28% | Q2 2020 | Q2 2023 | 13 |
MYOK | MYOKARDIA INC | 13 | 13 | 0.18% | 0.83% | 1.66% | Q3 2017 | Q3 2020 | 13 |
CLDX | CELLDEX THERAPEUTICS I... | 13 | 13 | 0.13% | 0.72% | 1.29% | Q2 2020 | Q2 2023 | 13 |
A | AGILENT TECHNOLOGIES INC | 13 | 13 | 0.05% | 0.41% | 0.91% | Q3 2019 | Q3 2022 | 13 |
BOLD | AUDENTES THERAPEUTICS INC | 13 | 13 | 0.24% | 0.38% | 0.67% | Q3 2016 | Q3 2019 | 13 |
VYGR | VOYAGER THERAPEUTICS INC | 13 | 13 | 0.15% | 0.36% | 0.66% | Q4 2015 | Q4 2018 | 13 |
CRNX | CRINETICS PHARMACEUTIC... | 11 | 2 | 0.06% | 0.32% | 0.67% | Q3 2018 | Q2 2023 | 13 |
STE | STERIS PLC | 13 | 13 | 0.06% | 0.31% | 0.51% | Q2 2020 | Q2 2023 | 13 |
INSM | INSMED INC | 10 | 3 | 0.12% | 0.20% | 0.32% | Q4 2013 | Q2 2023 | 13 |
OMED | ONCOMED PHARMACEUTICAL... | 13 | 13 | 0.10% | 0.16% | 0.28% | Q4 2013 | Q4 2016 | 13 |
SEP | SPECTRA ENERGY PARTNER... | 13 | 13 | 0.01% | 0.08% | 0.14% | Q3 2015 | Q3 2018 | 13 |
APU | AMERIGAS PARTNERS L P | 9 | 4 | 0.01% | 0.04% | 0.06% | Q1 2016 | Q2 2019 | 13 |
VTR | VENTAS INC | 10 | 1 | 0.01% | 0.03% | 0.06% | Q1 2016 | Q3 2019 | 13 |
CPN | CALPINE CORP | 12 | 12 | 0.39% | 1.34% | 1.81% | Q4 2013 | Q3 2016 | 12 |
INST | INSTRUCTURE INC | 12 | 12 | 0.42% | 1.17% | 1.86% | Q4 2016 | Q3 2019 | 12 |
SPT | SPROUT SOCIAL INC | 12 | 12 | 0.71% | 1.06% | 1.60% | Q3 2020 | Q2 2023 | 12 |
MPWR | MONOLITHIC PWR SYS INC | 12 | 12 | 0.39% | 0.66% | 0.97% | Q3 2020 | Q2 2023 | 12 |
IMVT | IMMUNOVANT INC | 12 | 12 | 0.33% | 0.58% | 1.29% | Q2 2020 | Q1 2023 | 12 |
ONCE | SPARK THERAPEUTICS INC | 12 | 12 | 0.12% | 0.56% | 1.64% | Q2 2015 | Q1 2018 | 12 |
WVE | WAVE LIFE SCIENCES LTD | 12 | 12 | 0.23% | 0.55% | 0.79% | Q2 2016 | Q1 2019 | 12 |
BEPC | BROOKFIELD RENEWABLE CORP | 12 | 12 | 0.33% | 0.48% | 0.68% | Q3 2020 | Q2 2023 | 12 |
LSCC | LATTICE SEMICONDUCTOR ... | 12 | 12 | 0.01% | 0.40% | 0.90% | Q3 2020 | Q2 2023 | 12 |
ADCT | ADC THERAPEUTICS SA | 12 | 12 | 0.06% | 0.33% | 0.53% | Q2 2020 | Q1 2023 | 12 |
AGTC | APPLIED GENETIC TECHNO... | 12 | 12 | 0.08% | 0.29% | 0.65% | Q2 2014 | Q1 2017 | 12 |
SNPS | SYNOPSYS INC | 12 | 12 | 0.04% | 0.28% | 0.58% | Q3 2020 | Q2 2023 | 12 |
CEMP | CEMPRA INC | 12 | 12 | 0.18% | 0.27% | 0.40% | Q4 2013 | Q3 2016 | 12 |
NDAQ | NASDAQ INC | 11 | 1 | 0.02% | 0.25% | 0.57% | Q2 2020 | Q2 2023 | 12 |
ELS | EQUITY LIFESTYLE PPTYS... | 10 | 2 | 0.01% | 0.18% | 0.30% | Q1 2020 | Q2 2023 | 12 |
SYY | SYSCO CORP | 12 | 12 | 0.04% | 0.17% | 0.29% | Q3 2020 | Q2 2023 | 12 |
FHB | FIRST HAWAIIAN INC | 12 | 12 | 0.02% | 0.08% | 0.12% | Q3 2016 | Q2 2019 | 12 |
HMC | HONDA MOTOR LTD | 11 | 1 | 0.01% | 0.08% | 0.10% | Q3 2016 | Q3 2019 | 12 |
NYLD | NRG YIELD INC | 12 | 12 | 0.00% | 0.05% | 0.08% | Q3 2015 | Q2 2018 | 12 |
ZGNX | ZOGENIX INC | 11 | 11 | 0.35% | 2.30% | 4.17% | Q4 2017 | Q2 2020 | 11 |
MDVN | MEDIVATION INC | 11 | 11 | 0.55% | 1.97% | 3.80% | Q4 2013 | Q2 2016 | 11 |
CBI | CHICAGO BRIDGE & IRON ... | 11 | 11 | 0.95% | 1.49% | 2.65% | Q4 2013 | Q2 2016 | 11 |
ZI | ZOOMINFO TECHNOLOGIES INC | 11 | 11 | 0.00% | 1.47% | 2.08% | Q3 2020 | Q1 2023 | 11 |
LLTC | LINEAR TECHNOLOGY CORP | 11 | 11 | 0.62% | 1.26% | 2.06% | Q4 2013 | Q2 2016 | 11 |
UFS | DOMTAR CORP | 11 | 11 | 0.43% | 1.09% | 2.25% | Q4 2013 | Q2 2016 | 11 |
CAFD | 8POINT3 ENERGY PARTNER... | 11 | 11 | 0.21% | 1.07% | 1.39% | Q3 2015 | Q1 2018 | 11 |
MGTA | MAGENTA THERAPEUTICS INC | 11 | 11 | 0.12% | 0.88% | 1.71% | Q2 2018 | Q4 2020 | 11 |
SMAR | SMARTSHEET INC | 11 | 11 | 0.41% | 0.80% | 1.27% | Q3 2019 | Q1 2022 | 11 |
AVRO | AVROBIO INC | 11 | 11 | 0.28% | 0.76% | 1.70% | Q2 2018 | Q4 2020 | 11 |
PAYC | PAYCOM SOFTWARE INC | 10 | 1 | 0.01% | 0.54% | 0.98% | Q3 2017 | Q1 2021 | 11 |
ANNX | ANNEXON INC | 11 | 11 | 0.13% | 0.52% | 1.03% | Q3 2020 | Q1 2023 | 11 |
MASS | 908 DEVICES INC | 11 | 11 | 0.17% | 0.36% | 0.66% | Q4 2020 | Q2 2023 | 11 |
SNDX | SYNDAX PHARMACEUTICALS... | 9 | 2 | 0.08% | 0.29% | 0.67% | Q2 2017 | Q1 2022 | 11 |
ETNB | 89BIO INC | 9 | 2 | 0.12% | 0.27% | 0.44% | Q4 2019 | Q2 2023 | 11 |
PNR | PENTAIR PLC | 11 | 11 | 0.08% | 0.26% | 0.36% | Q4 2020 | Q2 2023 | 11 |
PHAT | PHATHOM PHARMACEUTICAL... | 11 | 11 | 0.06% | 0.25% | 0.40% | Q4 2019 | Q2 2022 | 11 |
FRLN | FREELINE THERAPEUTICS ... | 11 | 11 | 0.04% | 0.24% | 0.70% | Q3 2020 | Q1 2023 | 11 |
INCY | INCYTE CORP | 11 | 11 | 0.12% | 0.24% | 0.35% | Q1 2016 | Q3 2018 | 11 |
TGTX | TG THERAPEUTICS INC | 11 | 11 | 0.16% | 0.23% | 0.32% | Q2 2014 | Q4 2016 | 11 |
CDTX | CIDARA THERAPEUTICS INC | 11 | 11 | 0.06% | 0.15% | 0.23% | Q2 2015 | Q4 2017 | 11 |
NEE | NEXTERA ENERGY INC | 6 | 2 | 0.00% | 0.06% | 0.14% | Q2 2019 | Q2 2023 | 11 |
ZTS | ZOETIS INC | 8 | 3 | 0.01% | 0.05% | 0.09% | Q4 2019 | Q1 2023 | 11 |
WBK | WESTPAC BKG CORP | 11 | 11 | 0.00% | 0.03% | 0.05% | Q3 2015 | Q1 2018 | 11 |
RHT | RED HAT INC | 10 | 10 | 1.91% | 2.37% | 2.85% | Q4 2013 | Q1 2016 | 10 |
DT | DYNATRACE INC | 10 | 10 | 0.59% | 1.82% | 2.56% | Q4 2019 | Q1 2022 | 10 |
CYBR | CYBERARK SOFTWARE LTD | 10 | 10 | 0.80% | 1.75% | 2.30% | Q2 2015 | Q3 2017 | 10 |
PTLA | PORTOLA PHARMACEUTICAL... | 10 | 10 | 0.45% | 1.18% | 1.48% | Q4 2013 | Q1 2016 | 10 |
VRNS | VARONIS SYS INC | 10 | 10 | 0.42% | 1.11% | 1.96% | Q4 2017 | Q1 2020 | 10 |
LGND | LIGAND PHARMACEUTICALS... | 10 | 10 | 0.43% | 0.96% | 2.18% | Q4 2013 | Q1 2016 | 10 |
DOOR | MASONITE INTL CORP NEW | 10 | 10 | 0.34% | 0.86% | 1.64% | Q3 2016 | Q4 2018 | 10 |
ROL | ROLLINS INC | 7 | 3 | 0.33% | 0.71% | 1.45% | Q3 2016 | Q3 2021 | 10 |
MNTA | MOMENTA PHARMACEUTICAL... | 10 | 10 | 0.34% | 0.70% | 1.07% | Q1 2018 | Q2 2020 | 10 |
SHLS | SHOALS TECHNOLOGIES GR... | 10 | 10 | 0.17% | 0.55% | 1.06% | Q1 2021 | Q2 2023 | 10 |
REGN | REGENERON PHARMACEUTICALS | 6 | 4 | 0.15% | 0.31% | 0.49% | Q2 2017 | Q4 2020 | 10 |
TCON | TRACON PHARMACEUTICALS... | 10 | 10 | 0.13% | 0.20% | 0.28% | Q3 2015 | Q4 2017 | 10 |
SYRS | SYROS PHARMACEUTICALS INC | 10 | 10 | 0.06% | 0.11% | 0.17% | Q2 2016 | Q3 2018 | 10 |
TNDM | TANDEM DIABETES CARE INC | 10 | 10 | 0.04% | 0.11% | 0.18% | Q3 2014 | Q4 2016 | 10 |
RXDX | PROMETHEUS BIOSCIENCES... | 9 | 9 | 0.97% | 1.74% | 3.10% | Q1 2021 | Q1 2023 | 9 |
SYNA | SYNAPTICS INC | 9 | 9 | 1.28% | 1.64% | 1.87% | Q2 2014 | Q2 2016 | 9 |
DATA | TABLEAU SOFTWARE INC | 9 | 9 | 0.81% | 1.57% | 2.14% | Q2 2014 | Q2 2016 | 9 |
EOG | EOG RES INC | 9 | 9 | 0.51% | 1.41% | 2.30% | Q4 2013 | Q4 2015 | 9 |
SNA | SNAP ON INC | 9 | 9 | 0.62% | 1.25% | 1.79% | Q3 2016 | Q3 2018 | 9 |
ARW | ARROW ELECTRS INC | 9 | 9 | 0.92% | 1.23% | 1.44% | Q2 2016 | Q2 2018 | 9 |
GNRC | GENERAC HLDGS INC | 8 | 1 | 0.00% | 1.18% | 1.76% | Q4 2020 | Q1 2023 | 9 |
SCTY | SOLARCITY CORP | 9 | 9 | 0.52% | 1.06% | 2.00% | Q4 2013 | Q4 2015 | 9 |
PRAX | PRAXIS PRECISION MEDIC... | 9 | 9 | 0.16% | 0.94% | 2.82% | Q4 2020 | Q4 2022 | 9 |
XMTR | XOMETRY INC | 9 | 9 | 0.02% | 0.89% | 1.80% | Q2 2021 | Q2 2023 | 9 |
CLDX | CELLDEX THERAPEUTICS I... | 9 | 9 | 0.14% | 0.66% | 1.92% | Q4 2013 | Q4 2015 | 9 |
NVT | NVENT ELECTRIC PLC | 9 | 9 | 0.24% | 0.50% | 0.70% | Q2 2021 | Q2 2023 | 9 |
OKTA | OKTA INC | 9 | 9 | 0.32% | 0.44% | 0.56% | Q1 2019 | Q1 2021 | 9 |
ALLK | ALLAKOS INC | 8 | 1 | 0.01% | 0.37% | 0.88% | Q3 2018 | Q4 2021 | 9 |
CCXI | CHEMOCENTRYX INC | 9 | 9 | 0.22% | 0.33% | 0.48% | Q2 2020 | Q2 2022 | 9 |
ICPT | INTERCEPT PHARMACEUTIC... | 6 | 1 | 0.07% | 0.33% | 0.79% | Q4 2018 | Q1 2023 | 9 |
RARX | RA PHARMACEUTICALS INC | 7 | 2 | 0.08% | 0.28% | 0.68% | Q2 2017 | Q3 2019 | 9 |
ESSA PHARMA INC | 9 | 9 | 0.03% | 0.26% | 0.49% | Q1 2016 | Q1 2018 | 9 | |
CIEN | CIENA CORP | 9 | 9 | 0.03% | 0.20% | 0.31% | Q2 2020 | Q2 2022 | 9 |
TERP | TERRAFORM PWR INC | 5 | 4 | 0.00% | 0.13% | 1.03% | Q3 2015 | Q4 2017 | 9 |
MLHR | MILLER HERMAN INC | 9 | 9 | 0.01% | 0.05% | 0.07% | Q4 2017 | Q4 2019 | 9 |
GLBL | TERRAFORM GLOBAL INC | 9 | 9 | 0.00% | 0.05% | 0.26% | Q3 2015 | Q3 2017 | 9 |
MBBYF | MOBILEYE N V AMSTELVEEN | 8 | 8 | 1.56% | 2.08% | 2.47% | Q1 2015 | Q4 2016 | 8 |
SUNEQ | SUNEDISON INC | 8 | 8 | 1.18% | 1.92% | 2.55% | Q4 2013 | Q3 2015 | 8 |
DYAX | DYAX CORP | 8 | 8 | 1.61% | 1.88% | 2.40% | Q4 2013 | Q3 2015 | 8 |
DLO | DLOCAL LTD | 8 | 8 | 0.36% | 1.51% | 2.00% | Q3 2021 | Q2 2023 | 8 |
GLBE | GLOBAL E ONLINE LTD | 8 | 8 | 0.45% | 1.29% | 1.73% | Q3 2021 | Q2 2023 | 8 |
GH | GUARDANT HEALTH INC | 8 | 8 | 0.29% | 1.27% | 2.42% | Q3 2021 | Q2 2023 | 8 |
ININ | INTERACTIVE INTELLIGEN... | 8 | 8 | 0.31% | 0.96% | 1.92% | Q4 2013 | Q3 2015 | 8 |
CMRE | COSTAMARE INC | 8 | 8 | 0.26% | 0.78% | 1.20% | Q4 2013 | Q3 2015 | 8 |
SGMO | SANGAMO BIOSCIENCES INC | 8 | 8 | 0.16% | 0.72% | 1.30% | Q4 2013 | Q3 2015 | 8 |
COUR | COURSERA INC | 8 | 8 | 0.33% | 0.67% | 0.90% | Q3 2021 | Q2 2023 | 8 |
PWR | QUANTA SVCS INC | 8 | 8 | 0.33% | 0.63% | 0.93% | Q4 2013 | Q3 2015 | 8 |
YETI | YETI HLDGS INC | 8 | 8 | 0.21% | 0.60% | 0.85% | Q4 2020 | Q3 2022 | 8 |
BCYC | BICYCLE THERAPEUTICS PLC | 8 | 8 | 0.18% | 0.54% | 0.98% | Q1 2021 | Q4 2022 | 8 |
AYI | ACUITY BRANDS INC | 8 | 8 | 0.02% | 0.54% | 1.50% | Q3 2016 | Q2 2018 | 8 |
KITE | KITE PHARMA INC | 8 | 8 | 0.37% | 0.48% | 0.66% | Q3 2015 | Q2 2017 | 8 |
NRIX | NURIX THERAPEUTICS INC | 8 | 8 | 0.31% | 0.47% | 0.69% | Q3 2020 | Q2 2022 | 8 |
KURA | KURA ONCOLOGY INC | 8 | 8 | 0.20% | 0.43% | 0.70% | Q3 2020 | Q2 2022 | 8 |
WMB | WILLIAMS COS INC DEL | 7 | 1 | 0.05% | 0.35% | 0.50% | Q3 2019 | Q2 2023 | 8 |
VECT | VECTIVBIO HLDG AG | 8 | 8 | 0.14% | 0.33% | 0.58% | Q2 2021 | Q1 2023 | 8 |
ESI | ELEMENT SOLUTIONS INC | 8 | 8 | 0.13% | 0.28% | 0.37% | Q3 2021 | Q2 2023 | 8 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 7 | 1 | 0.16% | 0.26% | 0.40% | Q1 2015 | Q2 2023 | 8 |
BRKR | BRUKER CORP | 5 | 3 | 0.16% | 0.24% | 0.32% | Q4 2013 | Q2 2023 | 8 |
GXO LOGISTICS INCORPOR... | 8 | 8 | 0.15% | 0.21% | 0.26% | Q3 2021 | Q2 2023 | 8 | |
CMS | CMS ENERGY CORP | 5 | 3 | 0.07% | 0.21% | 0.41% | Q4 2019 | Q2 2023 | 8 |
CSII | CARDIOVASCULAR SYS INC... | 8 | 8 | 0.11% | 0.20% | 0.26% | Q4 2013 | Q3 2015 | 8 |
ZSAN | ZOSANO PHARMA CORP | 8 | 8 | 0.01% | 0.19% | 0.63% | Q1 2015 | Q4 2016 | 8 |
TALS | TALARIS THERAPEUTICS INC | 8 | 8 | 0.03% | 0.18% | 0.30% | Q2 2021 | Q1 2023 | 8 |
SNV | SYNOVUS FINL CORP | 8 | 8 | 0.08% | 0.16% | 0.27% | Q1 2021 | Q4 2022 | 8 |
PALO ALTO NETWORKS INC | 6 | 2 | 0.06% | 0.15% | 0.25% | Q3 2019 | Q1 2022 | 8 | |
ARAY | ACCURAY INC | 4 | 4 | 0.09% | 0.13% | 0.26% | Q1 2015 | Q1 2017 | 8 |
MDSO | MEDIDATA SOLUTIONS INC | 8 | 8 | 0.05% | 0.11% | 0.26% | Q4 2013 | Q3 2015 | 8 |
FHN | FIRST HORIZON NATL CORP | 6 | 2 | 0.04% | 0.11% | 0.22% | Q3 2019 | Q3 2021 | 8 |
EQIX | EQUINIX INC | 6 | 1 | 0.03% | 0.10% | 0.19% | Q3 2019 | Q2 2023 | 8 |
HANNON ARMSTRONG SUST ... | 8 | 8 | 0.05% | 0.06% | 0.08% | Q3 2017 | Q2 2019 | 8 | |
HTGC | HERCULES TECH GROWTH C... | 8 | 8 | 0.01% | 0.06% | 0.10% | Q3 2015 | Q2 2017 | 8 |
CCIPRA | CROWN CASTLE INTL CORP... | 7 | 1 | 0.01% | 0.05% | 0.06% | Q3 2017 | Q1 2020 | 8 |
SLAB | SILICON LABORATORIES INC | 8 | 8 | 0.01% | 0.03% | 0.06% | Q3 2020 | Q2 2022 | 8 |
ACORDA THERAPEUTICS INC | 8 | 8 | 0.01% | 0.02% | 0.02% | Q2 2017 | Q1 2019 | 8 | |
CMRX | CHIMERIX INC | 7 | 7 | 1.19% | 1.41% | 1.84% | Q1 2014 | Q3 2015 | 7 |
NRG | NRG ENERGY INC | 7 | 7 | 0.96% | 1.28% | 1.71% | Q4 2013 | Q2 2015 | 7 |
PLRX | PLIANT THERAPEUTICS INC | 7 | 7 | 0.01% | 1.00% | 1.92% | Q2 2020 | Q4 2021 | 7 |
RNG | RINGCENTRAL INC | 7 | 7 | 0.42% | 0.93% | 1.26% | Q1 2020 | Q3 2021 | 7 |
LNG | CHENIERE ENERGY INC | 7 | 7 | 0.08% | 0.86% | 1.32% | Q4 2021 | Q2 2023 | 7 |
ZYME | ZYMEWORKS INC | 7 | 7 | 0.55% | 0.85% | 1.49% | Q1 2021 | Q3 2022 | 7 |
ANET | ARISTA NETWORKS INC | 7 | 7 | 0.64% | 0.84% | 1.27% | Q1 2018 | Q3 2019 | 7 |
VITL | VITAL FARMS INC | 7 | 7 | 0.18% | 0.65% | 0.97% | Q4 2020 | Q2 2022 | 7 |
COGT | COGENT BIOSCIENCES INC | 7 | 7 | 0.38% | 0.64% | 0.98% | Q4 2021 | Q2 2023 | 7 |
SWKS | SKYWORKS SOLUTIONS INC | 7 | 7 | 0.33% | 0.40% | 0.45% | Q1 2020 | Q3 2021 | 7 |
CSLT | CASTLIGHT HEALTH INC | 7 | 7 | 0.19% | 0.33% | 0.43% | Q2 2015 | Q4 2016 | 7 |
WEC | WEC ENERGY GROUP INC | 5 | 2 | 0.06% | 0.24% | 0.41% | Q1 2020 | Q1 2023 | 7 |
SAAS | INCONTACT INC | 7 | 7 | 0.08% | 0.24% | 0.46% | Q4 2013 | Q2 2015 | 7 |
ACRS | ACLARIS THERAPEUTICS INC | 7 | 7 | 0.12% | 0.23% | 0.39% | Q3 2016 | Q1 2018 | 7 |
EPZM | EPIZYME INC | 7 | 7 | 0.16% | 0.23% | 0.31% | Q1 2016 | Q3 2017 | 7 |
AESC | AES CORP | 7 | 7 | 0.12% | 0.23% | 0.34% | Q2 2021 | Q4 2022 | 7 |
LW | LAMB WESTON HLDGS INC | 7 | 7 | 0.02% | 0.22% | 0.45% | Q3 2019 | Q1 2021 | 7 |
SNSS | SUNESIS PHARMACEUTICAL... | 7 | 7 | 0.00% | 0.20% | 0.44% | Q3 2017 | Q1 2019 | 7 |
BCRX | BIOCRYST PHARMACEUTICA... | 3 | 2 | 0.07% | 0.19% | 0.37% | Q2 2017 | Q2 2023 | 7 |
CHRS | COHERUS BIOSCIENCES INC | 7 | 7 | 0.11% | 0.18% | 0.27% | Q1 2016 | Q3 2017 | 7 |
ROIVANT SCIENCES LTD | 7 | 7 | 0.09% | 0.18% | 0.29% | Q4 2021 | Q2 2023 | 7 | |
DERM | DERMIRA INC | 7 | 7 | 0.11% | 0.16% | 0.22% | Q2 2017 | Q4 2018 | 7 |
FEIC | FEI CO | 7 | 7 | 0.07% | 0.15% | 0.24% | Q4 2013 | Q2 2015 | 7 |
PTCT | PTC THERAPEUTICS INC | 6 | 1 | 0.03% | 0.13% | 0.42% | Q3 2017 | Q1 2023 | 7 |
EGP | EASTGROUP PPTYS INC | 7 | 7 | 0.09% | 0.13% | 0.17% | Q4 2021 | Q2 2023 | 7 |
CTMX | CYTOMX THERAPEUTICS INC | 7 | 7 | 0.09% | 0.12% | 0.17% | Q4 2015 | Q2 2017 | 7 |
IMDZ | IMMUNE DESIGN CORP | 7 | 7 | 0.08% | 0.12% | 0.18% | Q1 2015 | Q3 2016 | 7 |
XOMA | XOMA CORP DEL | 7 | 7 | 0.03% | 0.12% | 0.25% | Q4 2013 | Q2 2015 | 7 |
PHVS | PHARVARIS N V | 7 | 7 | 0.05% | 0.12% | 0.21% | Q1 2021 | Q3 2022 | 7 |
GRMN | GARMIN LTD | 7 | 7 | 0.04% | 0.09% | 0.12% | Q4 2020 | Q2 2022 | 7 |
AWK | AMERICAN WTR WKS CO IN... | 7 | 7 | 0.07% | 0.08% | 0.10% | Q2 2020 | Q4 2021 | 7 |
JKHY | HENRY JACK & ASSOC INC | 7 | 7 | 0.04% | 0.07% | 0.11% | Q1 2020 | Q3 2021 | 7 |
TERP | TERRAFORM PWR INC | 7 | 7 | 0.04% | 0.07% | 0.09% | Q1 2018 | Q3 2019 | 7 |
RPTP | RAPTOR PHARMACEUTICAL ... | 7 | 7 | 0.01% | 0.06% | 0.16% | Q4 2013 | Q2 2015 | 7 |
NEUROCRINE BIOSCIENCES... | 7 | 7 | 0.02% | 0.05% | 0.06% | Q3 2019 | Q1 2021 | 7 | |
ARTERIS INC | 7 | 7 | 0.03% | 0.04% | 0.05% | Q4 2021 | Q2 2023 | 7 | |
OM | OUTSET MED INC | 7 | 7 | 0.01% | 0.03% | 0.05% | Q3 2020 | Q1 2022 | 7 |
FVRR | FIVERR INTL LTD | 6 | 6 | 0.64% | 1.46% | 1.76% | Q2 2020 | Q3 2021 | 6 |
TEX | TEREX CORP NEW | 6 | 6 | 0.70% | 1.24% | 2.09% | Q1 2014 | Q2 2015 | 6 |
OII | OCEANEERING INTL INC | 6 | 6 | 0.53% | 1.09% | 1.99% | Q4 2013 | Q1 2015 | 6 |
TRILLIUM THERAPEUTICS INC | 6 | 6 | 0.45% | 1.01% | 1.24% | Q2 2020 | Q3 2021 | 6 | |
FC | FRANKLIN COVEY CO | 6 | 6 | 0.33% | 0.89% | 1.66% | Q4 2013 | Q1 2015 | 6 |
NLNK | NEWLINK GENETICS CORP | 6 | 6 | 0.64% | 0.88% | 1.07% | Q4 2013 | Q1 2015 | 6 |
TPTX | TURNING POINT THERAPEU... | 6 | 6 | 0.51% | 0.68% | 1.09% | Q2 2020 | Q3 2021 | 6 |
ENPH | ENPHASE ENERGY INC | 6 | 6 | 0.16% | 0.62% | 0.89% | Q4 2021 | Q1 2023 | 6 |
AZPN | ASPEN TECHNOLOGY INC | 6 | 6 | 0.20% | 0.54% | 0.84% | Q1 2014 | Q2 2015 | 6 |
KALA | KALA PHARMACEUTICALS INC | 5 | 1 | 0.08% | 0.49% | 0.84% | Q3 2017 | Q1 2021 | 6 |
IFRX | INFLARX NV | 6 | 6 | 0.30% | 0.36% | 0.44% | Q4 2017 | Q1 2019 | 6 |
ARYAU | ARYA SCIENCES ACQUISIT... | 6 | 6 | 0.26% | 0.29% | 0.36% | Q4 2018 | Q1 2020 | 6 |
TRGP | TARGA RES CORP | 6 | 6 | 0.04% | 0.25% | 0.50% | Q1 2022 | Q2 2023 | 6 |
VBIV | VBI VACCINES INC | 6 | 6 | 0.12% | 0.22% | 0.41% | Q4 2017 | Q1 2019 | 6 |
JUNO | JUNO THERAPEUTICS INC | 6 | 6 | 0.11% | 0.17% | 0.21% | Q4 2015 | Q1 2017 | 6 |
IRWD | IRONWOOD PHARMACEUTICA... | 6 | 6 | 0.13% | 0.16% | 0.23% | Q2 2017 | Q3 2018 | 6 |
PCRX | PACIRA PHARMACEUTICALS... | 6 | 6 | 0.09% | 0.16% | 0.24% | Q4 2013 | Q1 2015 | 6 |
AQXP | AQUINOX PHARMACEUTICAL... | 6 | 6 | 0.11% | 0.15% | 0.19% | Q4 2016 | Q1 2018 | 6 |
ORTX | ORCHARD THERAPEUTICS PLC | 6 | 6 | 0.07% | 0.12% | 0.19% | Q4 2018 | Q1 2020 | 6 |
DSGN | DESIGN THERAPEUTICS INC | 6 | 6 | 0.08% | 0.11% | 0.18% | Q1 2021 | Q2 2022 | 6 |
INFI | INFINITY PHARMACEUTICA... | 6 | 6 | 0.07% | 0.11% | 0.18% | Q4 2014 | Q1 2016 | 6 |
CBIO | CATALYST BIOSCIENCES INC | 6 | 6 | 0.08% | 0.10% | 0.13% | Q2 2018 | Q3 2019 | 6 |
TFX | TELEFLEX INC | 6 | 6 | 0.05% | 0.09% | 0.17% | Q4 2013 | Q1 2015 | 6 |
MSCI | MSCI INC | 5 | 1 | 0.03% | 0.08% | 0.24% | Q2 2020 | Q2 2023 | 6 |
WM | WASTE MGMT INC DEL | 6 | 6 | 0.04% | 0.07% | 0.09% | Q2 2019 | Q3 2020 | 6 |
FOUR | SHIFT4 PMTS INC | 6 | 6 | 0.04% | 0.06% | 0.07% | Q4 2020 | Q1 2022 | 6 |
ZBH | ZIMMER BIOMET HOLDINGS... | 6 | 6 | 0.05% | 0.05% | 0.07% | Q4 2019 | Q1 2021 | 6 |
IR | INGERSOLL-RAND PLC | 4 | 2 | 0.02% | 0.05% | 0.08% | Q2 2018 | Q4 2019 | 6 |
CVA | COVANTA HLDG CORP | 6 | 6 | 0.02% | 0.04% | 0.05% | Q4 2017 | Q1 2019 | 6 |
GPMT | GRANITE PT MTG TR INC | 5 | 1 | 0.01% | 0.04% | 0.06% | Q1 2018 | Q3 2019 | 6 |
NXPI | NXP SEMICONDUCTORS N V | 3 | 1 | 0.00% | 0.03% | 0.05% | Q1 2019 | Q4 2022 | 6 |
CIG | COMPANHIA ENERGETICA D... | 6 | 6 | 0.01% | 0.03% | 0.04% | Q4 2017 | Q1 2019 | 6 |
BBN | BLACKROCK TAX MUNICPAL... | 6 | 6 | 0.01% | 0.02% | 0.02% | Q3 2015 | Q4 2016 | 6 |
NSC | NORFOLK SOUTHERN CORP | 6 | 6 | 0.01% | 0.01% | 0.02% | Q3 2015 | Q4 2016 | 6 |
TRW | TRW AUTOMOTIVE HLDGS CORP | 5 | 5 | 2.23% | 2.48% | 2.80% | Q4 2013 | Q4 2014 | 5 |
DOCS | DOXIMITY INC | 5 | 5 | 1.13% | 2.22% | 3.12% | Q2 2022 | Q2 2023 | 5 |
AVXS | AVEXIS INC | 5 | 5 | 0.41% | 1.77% | 2.44% | Q1 2017 | Q1 2018 | 5 |
MEOH | METHANEX CORP | 5 | 5 | 1.01% | 1.76% | 2.21% | Q4 2013 | Q4 2014 | 5 |
XYL | XYLEM INC | 5 | 5 | 1.08% | 1.66% | 2.07% | Q1 2019 | Q1 2020 | 5 |
LYB | LYONDELLBASELL INDUSTR... | 5 | 5 | 1.16% | 1.66% | 2.04% | Q4 2013 | Q4 2014 | 5 |
PCYC | PHARMACYCLICS INC | 5 | 5 | 1.01% | 1.47% | 2.17% | Q4 2013 | Q4 2014 | 5 |
FLYW | FLYWIRE CORPORATION | 5 | 5 | 0.05% | 1.42% | 2.17% | Q2 2022 | Q2 2023 | 5 |
CCI | CROWN CASTLE INTL CORP | 5 | 5 | 1.01% | 1.28% | 1.50% | Q4 2013 | Q4 2014 | 5 |
HZNP | HORIZON THERAPEUTICS P... | 5 | 5 | 0.12% | 1.27% | 2.24% | Q2 2022 | Q2 2023 | 5 |
P103PS | NPS PHARMACEUTICALS INC | 5 | 5 | 0.81% | 1.26% | 2.27% | Q4 2013 | Q4 2014 | 5 |
CXP | COLUMBIA PPTY TR INC | 5 | 5 | 0.80% | 1.20% | 1.42% | Q1 2014 | Q1 2015 | 5 |
VMW | VMWARE INC | 5 | 5 | 0.60% | 1.07% | 1.32% | Q1 2014 | Q1 2015 | 5 |
EVH | EVOLENT HEALTH INC | 5 | 5 | 0.14% | 0.77% | 1.35% | Q2 2022 | Q2 2023 | 5 |
IMMU | IMMUNOMEDICS INC | 5 | 5 | 0.41% | 0.69% | 0.93% | Q2 2018 | Q2 2019 | 5 |
GTTN | GTT COMMUNICATIONS INC | 5 | 5 | 0.10% | 0.58% | 1.17% | Q4 2017 | Q4 2018 | 5 |
FOLD | AMICUS THERAPEUTICS INC | 5 | 5 | 0.31% | 0.58% | 0.76% | Q3 2018 | Q3 2019 | 5 |
SWAV | SHOCKWAVE MED INC | 5 | 5 | 0.10% | 0.52% | 1.17% | Q2 2022 | Q2 2023 | 5 |
CDW | CDW CORP | 5 | 5 | 0.28% | 0.48% | 0.61% | Q2 2022 | Q2 2023 | 5 |
REXR | REXFORD INDL RLTY INC | 5 | 5 | 0.14% | 0.45% | 0.70% | Q3 2021 | Q3 2022 | 5 |
CGEM | CULLINAN ONCOLOGY INC | 5 | 5 | 0.24% | 0.43% | 0.73% | Q1 2021 | Q1 2022 | 5 |
NARI | INARI MED INC | 5 | 5 | 0.09% | 0.40% | 0.58% | Q2 2022 | Q2 2023 | 5 |
INSP | INSPIRE MED SYS INC | 5 | 5 | 0.09% | 0.40% | 0.59% | Q2 2022 | Q2 2023 | 5 |
PRVA | PRIVIA HEALTH GROUP INC | 5 | 5 | 0.17% | 0.37% | 0.51% | Q2 2022 | Q2 2023 | 5 |
IRTC | IRHYTHM TECHNOLOGIES INC | 5 | 5 | 0.07% | 0.37% | 0.54% | Q2 2022 | Q2 2023 | 5 |
MAX | MEDIAALPHA INC | 5 | 5 | 0.04% | 0.35% | 0.67% | Q4 2020 | Q4 2021 | 5 |
ECYT | ENDOCYTE INC | 3 | 2 | 0.15% | 0.34% | 0.86% | Q4 2013 | Q3 2018 | 5 |
EIDX | EIDOS THERAPEUTICS INC | 4 | 1 | 0.14% | 0.33% | 0.64% | Q2 2018 | Q4 2020 | 5 |
KROS | KEROS THERAPEUTICS INC | 3 | 2 | 0.24% | 0.33% | 0.39% | Q4 2020 | Q2 2023 | 5 |
SLXP | SALIX PHARMACEUTICALS INC | 5 | 5 | 0.15% | 0.27% | 0.37% | Q4 2013 | Q4 2014 | 5 |
DCPH | DECIPHERA PHARMACEUTIC... | 4 | 1 | 0.18% | 0.26% | 0.32% | Q1 2020 | Q3 2021 | 5 |
HPTX | HYPERION THERAPEUTICS INC | 5 | 5 | 0.19% | 0.24% | 0.29% | Q4 2013 | Q4 2014 | 5 |
MCRB | SERES THERAPEUTICS INC | 5 | 5 | 0.13% | 0.24% | 0.32% | Q3 2015 | Q3 2016 | 5 |
KNSA | KINIKSA PHARMACEUTICAL... | 5 | 5 | 0.02% | 0.22% | 0.40% | Q2 2018 | Q2 2019 | 5 |
KPTI | KARYOPHARM THERAPEUTIC... | 5 | 5 | 0.12% | 0.20% | 0.32% | Q4 2013 | Q4 2014 | 5 |
CRDF | CARDIFF ONCOLOGY INC | 5 | 5 | 0.06% | 0.18% | 0.32% | Q1 2021 | Q1 2022 | 5 |
ACRX | ACELRX PHARMACEUTICALS... | 5 | 5 | 0.10% | 0.17% | 0.26% | Q4 2013 | Q4 2014 | 5 |
ALXO | ALX ONCOLOGY HLDGS INC | 3 | 2 | 0.06% | 0.17% | 0.32% | Q1 2021 | Q1 2023 | 5 |
LOB | LIVE OAK BANCSHARES INC | 5 | 5 | 0.05% | 0.15% | 0.30% | Q2 2021 | Q2 2022 | 5 |
MEIP | MEI PHARMA INC | 5 | 5 | 0.01% | 0.15% | 0.24% | Q4 2013 | Q4 2014 | 5 |
PTI | PROTEOSTASIS THERAPEUT... | 5 | 5 | 0.06% | 0.14% | 0.21% | Q1 2016 | Q1 2017 | 5 |
SBNY | SIGNATURE BK NEW YORK N Y | 5 | 5 | 0.05% | 0.13% | 0.20% | Q4 2020 | Q4 2021 | 5 |
SBAC | SBA COMMUNICATIONS COR... | 5 | 5 | 0.07% | 0.10% | 0.15% | Q4 2020 | Q4 2021 | 5 |
BOLT | BOLT BIOTHERAPEUTICS INC | 5 | 5 | 0.04% | 0.10% | 0.16% | Q1 2021 | Q1 2022 | 5 |
RGLS | REGULUS THERAPEUTICS INC | 5 | 5 | 0.06% | 0.10% | 0.15% | Q4 2014 | Q4 2015 | 5 |
IONS | IONIS PHARMACEUTICALS INC | 5 | 5 | 0.07% | 0.08% | 0.10% | Q2 2022 | Q2 2023 | 5 |
WMS | ADVANCED DRAIN SYS INC... | 5 | 5 | 0.02% | 0.08% | 0.11% | Q3 2021 | Q3 2022 | 5 |
KBH | KB HOME | 5 | 5 | 0.02% | 0.07% | 0.09% | Q2 2021 | Q2 2022 | 5 |
EXACT SCIENCES CORP | 5 | 5 | 0.03% | 0.06% | 0.07% | Q1 2020 | Q1 2021 | 5 | |
CPPL | COLUMBIA PIPELINE PART... | 5 | 5 | 0.01% | 0.03% | 0.06% | Q4 2015 | Q4 2016 | 5 |
VSTM | VERASTEM INC | 5 | 5 | 0.00% | 0.02% | 0.03% | Q2 2014 | Q2 2015 | 5 |
DOCU | DOCUSIGN INC | 5 | 5 | 0.01% | 0.02% | 0.02% | Q3 2020 | Q3 2021 | 5 |
QLIK | QLIK TECHNOLOGIES INC | 4 | 4 | 0.99% | 1.57% | 2.08% | Q2 2015 | Q1 2016 | 4 |
KNBE | KNOWBE4 INC | 4 | 4 | 0.85% | 1.28% | 1.52% | Q4 2021 | Q3 2022 | 4 |
DV | DOUBLEVERIFY HLDGS INC | 4 | 4 | 0.99% | 1.17% | 1.39% | Q3 2022 | Q2 2023 | 4 |
SPWR | SUNPOWER CORP | 4 | 4 | 0.75% | 1.11% | 1.50% | Q3 2015 | Q2 2016 | 4 |
ELLI | ELLIE MAE INC | 4 | 4 | 1.04% | 1.08% | 1.13% | Q3 2017 | Q2 2018 | 4 |
IMPV | IMPERVA INC | 4 | 4 | 0.91% | 1.08% | 1.21% | Q2 2015 | Q1 2016 | 4 |
MIRM | MIRUM PHARMACEUTICALS INC | 4 | 4 | 0.53% | 0.93% | 1.51% | Q3 2022 | Q2 2023 | 4 |
ORA | ORMAT TECHNOLOGIES INC | 4 | 4 | 0.27% | 0.62% | 0.82% | Q4 2015 | Q3 2016 | 4 |
DICE THERAPEUTICS INC | 4 | 4 | 0.44% | 0.59% | 0.78% | Q3 2021 | Q2 2022 | 4 | |
SGEN | SEAGEN INC | 3 | 1 | 0.28% | 0.59% | 1.04% | Q4 2020 | Q2 2023 | 4 |
PBYI | PUMA BIOTECHNOLOGY INC | 2 | 2 | 0.10% | 0.58% | 1.34% | Q4 2013 | Q4 2017 | 4 |
SZYM | SOLAZYME INC | 4 | 4 | 0.20% | 0.57% | 0.81% | Q4 2013 | Q3 2014 | 4 |
APLS | APELLIS PHARMACEUTICAL... | 4 | 4 | 0.35% | 0.50% | 0.61% | Q3 2022 | Q2 2023 | 4 |
VKTX | VIKING THERAPEUTICS INC | 3 | 1 | 0.20% | 0.48% | 0.60% | Q3 2018 | Q2 2023 | 4 |
BBIO | BRIDGEBIO PHARMA INC | 2 | 2 | 0.27% | 0.45% | 0.65% | Q1 2021 | Q2 2023 | 4 |
STSA | SATSUMA PHARMACEUTICAL... | 4 | 4 | 0.21% | 0.43% | 0.67% | Q3 2019 | Q2 2020 | 4 |
SLDB | SOLID BIOSCIENCES INC | 3 | 1 | 0.09% | 0.38% | 0.69% | Q1 2018 | Q1 2021 | 4 |
NTLA | INTELLIA THERAPEUTICS INC | 4 | 4 | 0.22% | 0.31% | 0.35% | Q3 2022 | Q2 2023 | 4 |
AJG | GALLAGHER ARTHUR J & CO | 4 | 4 | 0.11% | 0.31% | 0.42% | Q3 2022 | Q2 2023 | 4 |
CBST | CUBIST PHARMACEUTICALS... | 4 | 4 | 0.25% | 0.28% | 0.31% | Q4 2013 | Q3 2014 | 4 |
COMP | COMPASS INC | 3 | 1 | 0.01% | 0.26% | 0.54% | Q2 2021 | Q2 2023 | 4 |
THOR | SYNTHORX INC | 4 | 4 | 0.16% | 0.24% | 0.31% | Q4 2018 | Q3 2019 | 4 |
BEAM | BEAM THERAPEUTICS INC | 4 | 4 | 0.21% | 0.24% | 0.26% | Q3 2022 | Q2 2023 | 4 |
MKC | MCCORMICK & CO INC | 4 | 4 | 0.19% | 0.23% | 0.27% | Q1 2020 | Q4 2020 | 4 |
ARVN | ARVINAS INC | 3 | 1 | 0.11% | 0.20% | 0.30% | Q1 2020 | Q3 2022 | 4 |
EHC | ENCOMPASS HEALTH CORP | 4 | 4 | 0.17% | 0.20% | 0.23% | Q3 2022 | Q2 2023 | 4 |
ORIC | ORIC PHARMACEUTICALS INC | 4 | 4 | 0.16% | 0.20% | 0.22% | Q4 2020 | Q3 2021 | 4 |
UROV | UROVANT SCIENCES LTD | 4 | 4 | 0.10% | 0.20% | 0.26% | Q3 2018 | Q2 2019 | 4 |
ACHN | ACHILLION PHARMACEUTIC... | 4 | 4 | 0.13% | 0.19% | 0.24% | Q1 2017 | Q4 2017 | 4 |
WD | WALKER & DUNLOP INC | 4 | 4 | 0.15% | 0.19% | 0.25% | Q1 2022 | Q4 2022 | 4 |
CHMA | CHIASMA INC | 4 | 4 | 0.11% | 0.18% | 0.25% | Q2 2020 | Q1 2021 | 4 |
PTGX | PROTAGONIST THERAPEUTI... | 3 | 1 | 0.09% | 0.16% | 0.30% | Q2 2017 | Q2 2023 | 4 |
DLPH | DELPHI TECHNOLOGIES PLC | 4 | 4 | 0.06% | 0.11% | 0.14% | Q4 2017 | Q3 2018 | 4 |
SNSS | SUNESIS PHARMACEUTICAL... | 4 | 4 | 0.08% | 0.10% | 0.13% | Q4 2013 | Q3 2014 | 4 |
VFC | V F CORP | 4 | 4 | 0.03% | 0.08% | 0.10% | Q4 2020 | Q3 2021 | 4 |
EXACT SCIENCES CORP | 4 | 4 | 0.04% | 0.07% | 0.14% | Q1 2021 | Q4 2021 | 4 | |
GUARDANT HEALTH INC | 4 | 4 | 0.04% | 0.04% | 0.04% | Q4 2021 | Q3 2022 | 4 | |
DERMIRA INC | 4 | 4 | 0.02% | 0.03% | 0.04% | Q2 2018 | Q1 2019 | 4 | |
NOK | NOKIA CORP | 4 | 4 | 0.01% | 0.03% | 0.05% | Q4 2018 | Q3 2019 | 4 |
MEDICINES CO | 4 | 4 | 0.02% | 0.02% | 0.04% | Q4 2018 | Q3 2019 | 4 | |
JCI | JOHNSON CTLS INC | 4 | 4 | 0.01% | 0.02% | 0.04% | Q3 2015 | Q2 2016 | 4 |
PSA | PUBLIC STORAGE | 4 | 4 | 0.02% | 0.02% | 0.02% | Q2 2018 | Q1 2019 | 4 |
BAB | POWERSHARES ETF TR II | 4 | 4 | 0.01% | 0.01% | 0.01% | Q3 2015 | Q2 2016 | 4 |
NVDA | NVIDIA CORPORATION | 3 | 1 | 0.00% | 0.01% | 0.02% | Q3 2019 | Q2 2023 | 4 |
HERCULES CAPITAL INC | 4 | 4 | 0.01% | 0.01% | 0.01% | Q1 2018 | Q4 2018 | 4 | |
NATI | NATIONAL INSTRS CORP | 4 | 4 | 0.00% | 0.00% | 0.01% | Q3 2015 | Q2 2016 | 4 |
IGV | ISHARES TR | 3 | 3 | 2.01% | 2.40% | 2.99% | Q1 2020 | Q3 2020 | 3 |
FEYE | FIREEYE INC | 3 | 3 | 1.94% | 2.04% | 2.19% | Q4 2014 | Q2 2015 | 3 |
TRN | TRINITY INDS INC | 3 | 3 | 1.31% | 1.77% | 2.44% | Q4 2014 | Q2 2015 | 3 |
SDRL | SEADRILL LIMITED | 3 | 3 | 1.20% | 1.42% | 1.81% | Q4 2013 | Q2 2014 | 3 |
ALTR | ALTAIR ENGR INC | 3 | 3 | 0.80% | 1.20% | 1.60% | Q3 2018 | Q1 2019 | 3 |
JELD | JELD-WEN HLDG INC | 3 | 3 | 0.83% | 0.93% | 1.04% | Q4 2017 | Q2 2018 | 3 |
WSO | WATSCO INC | 3 | 3 | 0.77% | 0.83% | 0.87% | Q3 2016 | Q1 2017 | 3 |
IAA | IAA INC | 3 | 3 | 0.72% | 0.79% | 0.84% | Q2 2019 | Q4 2019 | 3 |
TLND | TALEND S A | 3 | 3 | 0.64% | 0.71% | 0.81% | Q4 2018 | Q2 2019 | 3 |
CSIQ | CANADIAN SOLAR INC | 3 | 3 | 0.56% | 0.69% | 0.87% | Q4 2015 | Q2 2016 | 3 |
KDNY | CHINOOK THERAPEUTICS INC | 3 | 3 | 0.19% | 0.68% | 1.25% | Q4 2022 | Q2 2023 | 3 |
RPRX | ROYALTY PHARMA PLC | 3 | 3 | 0.54% | 0.61% | 0.69% | Q4 2022 | Q2 2023 | 3 |
NCNO | NCINO INC | 3 | 3 | 0.48% | 0.55% | 0.62% | Q2 2021 | Q4 2021 | 3 |
ABY | ABENGOA YIELD PLC | 3 | 3 | 0.00% | 0.51% | 0.90% | Q3 2015 | Q1 2016 | 3 |
AURA BIOSCIENCES INC | 3 | 3 | 0.43% | 0.50% | 0.61% | Q4 2022 | Q2 2023 | 3 | |
DUOLINGO INC | 3 | 3 | 0.35% | 0.48% | 0.71% | Q4 2021 | Q2 2022 | 3 | |
AKCA | AKCEA THERAPEUTICS INC | 3 | 3 | 0.21% | 0.42% | 0.66% | Q3 2017 | Q1 2018 | 3 |
MARINUS PHARMACEUTICAL... | 3 | 3 | 0.25% | 0.41% | 0.58% | Q4 2022 | Q2 2023 | 3 | |
CYTK | CYTOKINETICS INC | 3 | 3 | 0.31% | 0.39% | 0.50% | Q4 2022 | Q2 2023 | 3 |
BILL | BILL HOLDINGS INC | 3 | 3 | 0.03% | 0.33% | 0.57% | Q3 2022 | Q1 2023 | 3 |
MDCO | MEDICINES CO | 3 | 3 | 0.28% | 0.33% | 0.37% | Q4 2018 | Q2 2019 | 3 |
SHC | SOTERA HEALTH CO | 3 | 3 | 0.28% | 0.32% | 0.37% | Q4 2020 | Q2 2021 | 3 |
ORLY | OREILLY AUTOMOTIVE INC | 3 | 3 | 0.00% | 0.32% | 0.49% | Q4 2022 | Q2 2023 | 3 |
MDGL | MADRIGAL PHARMACEUTICA... | 3 | 3 | 0.14% | 0.31% | 0.53% | Q1 2018 | Q3 2018 | 3 |
AMYLYX PHARMACEUTICALS... | 3 | 3 | 0.18% | 0.28% | 0.41% | Q4 2022 | Q2 2023 | 3 | |
BYND | BEYOND MEAT INC | 3 | 3 | 0.21% | 0.28% | 0.32% | Q1 2021 | Q3 2021 | 3 |
BFLY | BUTTERFLY NETWORK INC | 3 | 3 | 0.24% | 0.26% | 0.28% | Q1 2021 | Q3 2021 | 3 |
BAX | BAXTER INTL INC | 3 | 3 | 0.20% | 0.23% | 0.27% | Q2 2022 | Q4 2022 | 3 |
SBTX | SILVERBACK THERAPEUTIC... | 3 | 3 | 0.15% | 0.21% | 0.24% | Q4 2020 | Q2 2021 | 3 |
ADVM | ADVERUM BIOTECHNOLOGIE... | 3 | 3 | 0.16% | 0.21% | 0.26% | Q4 2018 | Q2 2019 | 3 |
IMGN | IMMUNOGEN INC | 2 | 1 | 0.08% | 0.20% | 0.42% | Q4 2021 | Q2 2023 | 3 |
APTVPRA | APTIV PLC | 2 | 1 | 0.15% | 0.19% | 0.21% | Q4 2021 | Q3 2022 | 3 |
AMBI | AMBIT BIOSCIENCES CORP | 3 | 3 | 0.14% | 0.18% | 0.22% | Q4 2013 | Q2 2014 | 3 |
APTVPRA | APTIV PLC | 2 | 1 | 0.17% | 0.18% | 0.20% | Q1 2022 | Q1 2023 | 3 |
WDAY | WORKDAY INC | 3 | 3 | 0.01% | 0.17% | 0.51% | Q4 2022 | Q2 2023 | 3 |
APTOSE BIOSCIENCES INC | 3 | 3 | 0.10% | 0.15% | 0.20% | Q4 2020 | Q2 2021 | 3 | |
AAVL | AVALANCHE BIOTECHNOLOG... | 3 | 3 | 0.10% | 0.13% | 0.19% | Q3 2014 | Q1 2015 | 3 |
ITT | ITT INC | 3 | 3 | 0.08% | 0.11% | 0.14% | Q2 2020 | Q4 2020 | 3 |
VICL | VICAL INC | 3 | 3 | 0.01% | 0.10% | 0.16% | Q4 2017 | Q2 2018 | 3 |
AQNU | ALGONQUIN PWR UTILS CORP | 3 | 3 | 0.08% | 0.09% | 0.09% | Q2 2021 | Q4 2021 | 3 |
RCUS | ARCUS BIOSCIENCES INC | 3 | 3 | 0.08% | 0.09% | 0.10% | Q4 2022 | Q2 2023 | 3 |
TMDX | TRANSMEDICS GROUP INC | 2 | 1 | 0.03% | 0.05% | 0.10% | Q2 2021 | Q2 2023 | 3 |
TER | TERADYNE INC | 3 | 3 | 0.02% | 0.05% | 0.08% | Q4 2019 | Q2 2020 | 3 |
HCP | HCP INC | 2 | 1 | 0.00% | 0.05% | 0.09% | Q3 2015 | Q3 2019 | 3 |
EIGR | EIGER BIOPHARMACEUTICA... | 3 | 3 | 0.02% | 0.05% | 0.09% | Q4 2017 | Q2 2018 | 3 |
AMD | ADVANCED MICRO DEVICES... | 3 | 3 | 0.01% | 0.02% | 0.04% | Q3 2020 | Q1 2021 | 3 |
SAREPTA THERAPEUTICS INC | 3 | 3 | 0.02% | 0.02% | 0.03% | Q4 2019 | Q2 2020 | 3 | |
BIP | BROOKFIELD INFRAST PAR... | 2 | 1 | 0.00% | 0.01% | 0.02% | Q4 2015 | Q4 2016 | 3 |
NOW | SERVICENOW INC | 3 | 3 | 0.00% | 0.01% | 0.01% | Q4 2022 | Q2 2023 | 3 |
EW | EDWARDS LIFESCIENCES CORP | 3 | 3 | 0.00% | 0.01% | 0.01% | Q4 2022 | Q2 2023 | 3 |
SYK | STRYKER CORP | 3 | 3 | 0.00% | 0.01% | 0.01% | Q3 2015 | Q1 2016 | 3 |
DLR | DIGITAL RLTY TR INC | 3 | 3 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q1 2016 | 3 |
SE | SPECTRA ENERGY CORP | 3 | 3 | 0.00% | 0.00% | 0.01% | Q3 2015 | Q1 2016 | 3 |
RMR | RMR GROUP INC | 3 | 3 | 0.00% | 0.00% | 0.00% | Q4 2015 | Q2 2016 | 3 |
SEND | SENDGRID INC | 2 | 2 | 2.66% | 3.04% | 3.43% | Q3 2018 | Q4 2018 | 2 |
ROC | ROCKWOOD HLDGS INC | 2 | 2 | 1.76% | 1.86% | 1.97% | Q1 2014 | Q2 2014 | 2 |
SERV | SERVICEMASTER GLOBAL H... | 2 | 2 | 1.10% | 1.24% | 1.38% | Q2 2019 | Q3 2019 | 2 |
FSLR | FIRST SOLAR INC | 2 | 2 | 0.38% | 1.03% | 1.68% | Q1 2016 | Q2 2016 | 2 |
SJM | SMUCKER J M CO | 2 | 2 | 0.70% | 0.93% | 1.15% | Q4 2013 | Q1 2014 | 2 |
LAD | LITHIA MTRS INC | 2 | 2 | 0.53% | 0.89% | 1.26% | Q1 2023 | Q2 2023 | 2 |
3106PS | DELPHI AUTOMOTIVE PLC | 2 | 2 | 0.86% | 0.87% | 0.88% | Q2 2017 | Q3 2017 | 2 |
NOV | NATIONAL OILWELL VARCO... | 2 | 2 | 0.57% | 0.87% | 1.16% | Q4 2013 | Q1 2014 | 2 |
ECL | ECOLAB INC | 2 | 2 | 0.76% | 0.83% | 0.90% | Q3 2020 | Q4 2020 | 2 |
ANAB | ANAPTYSBIO INC | 2 | 2 | 0.21% | 0.59% | 0.96% | Q2 2018 | Q3 2018 | 2 |
AKBA | AKEBIA THERAPEUTICS INC | 2 | 2 | 0.51% | 0.57% | 0.63% | Q2 2014 | Q3 2014 | 2 |
ESTC | ELASTIC N V | 2 | 2 | 0.41% | 0.49% | 0.58% | Q3 2019 | Q4 2019 | 2 |
BLU | BELLUS HEALTH INC NEW | 1 | 1 | 0.29% | 0.32% | 0.34% | Q2 2020 | Q1 2023 | 2 |
COG | CABOT OIL & GAS CORP | 2 | 2 | 0.18% | 0.30% | 0.42% | Q4 2013 | Q1 2014 | 2 |
RTRX | RETROPHIN INC | 2 | 2 | 0.28% | 0.29% | 0.30% | Q2 2015 | Q3 2015 | 2 |
AKRO | AKERO THERAPEUTICS INC | 2 | 2 | 0.27% | 0.28% | 0.30% | Q1 2023 | Q2 2023 | 2 |
SHPG | SHIRE PLC | 2 | 2 | 0.23% | 0.25% | 0.28% | Q4 2013 | Q1 2014 | 2 |
ARQL | ARQULE INC | 2 | 2 | 0.13% | 0.24% | 0.35% | Q4 2018 | Q1 2019 | 2 |
RXDX | IGNYTA INC | 2 | 2 | 0.22% | 0.23% | 0.24% | Q2 2017 | Q3 2017 | 2 |
HSACU | HEALTH SCIENCES ACQUST... | 2 | 2 | 0.22% | 0.23% | 0.24% | Q2 2019 | Q3 2019 | 2 |
ESPR | ESPERION THERAPEUTICS ... | 2 | 2 | 0.17% | 0.22% | 0.27% | Q1 2015 | Q2 2015 | 2 |
CERE | CEREVEL THERAPEUTICS H... | 2 | 2 | 0.14% | 0.20% | 0.26% | Q1 2023 | Q2 2023 | 2 |
ALDR | ALDER BIOPHARMACEUTICA... | 2 | 2 | 0.11% | 0.20% | 0.29% | Q4 2016 | Q1 2017 | 2 |
R1 RCM INC | 2 | 2 | 0.16% | 0.20% | 0.23% | Q1 2023 | Q2 2023 | 2 | |
ARWR | ARROWHEAD RESH CORP | 2 | 2 | 0.16% | 0.20% | 0.24% | Q2 2014 | Q3 2014 | 2 |
FMI | FOUNDATION MEDICINE INC | 2 | 2 | 0.08% | 0.17% | 0.25% | Q4 2013 | Q1 2014 | 2 |
BLCM | BELLICUM PHARMACEUTICA... | 2 | 2 | 0.11% | 0.16% | 0.22% | Q4 2016 | Q1 2017 | 2 |
IMTX | IMMATICS N.V | 2 | 2 | 0.13% | 0.15% | 0.17% | Q3 2020 | Q4 2020 | 2 |
DNLI | DENALI THERAPEUTICS INC | 2 | 2 | 0.13% | 0.14% | 0.16% | Q1 2023 | Q2 2023 | 2 |
ATHX | ATHERSYS INC | 2 | 2 | 0.13% | 0.14% | 0.14% | Q4 2013 | Q1 2014 | 2 |
OPCH | OPTION CARE HEALTH INC | 2 | 2 | 0.13% | 0.13% | 0.14% | Q2 2022 | Q3 2022 | 2 |
CERS | CERUS CORP | 2 | 2 | 0.07% | 0.13% | 0.19% | Q4 2013 | Q1 2014 | 2 |
IOVA | IOVANCE BIOTHERAPEUTIC... | 2 | 2 | 0.12% | 0.13% | 0.15% | Q2 2018 | Q3 2018 | 2 |
MDAS | MEDASSETS INC | 2 | 2 | 0.10% | 0.13% | 0.16% | Q4 2013 | Q1 2014 | 2 |
RMD | RESMED INC | 2 | 2 | 0.07% | 0.11% | 0.14% | Q4 2013 | Q1 2014 | 2 |
EQT | EQT CORP | 2 | 2 | 0.07% | 0.10% | 0.14% | Q3 2022 | Q4 2022 | 2 |
TIG | TIGENIX | 2 | 2 | 0.10% | 0.10% | 0.10% | Q4 2016 | Q1 2017 | 2 |
AEGR | AEGERION PHARMACEUTICA... | 2 | 2 | 0.09% | 0.09% | 0.09% | Q2 2014 | Q3 2014 | 2 |
AQN | ALGONQUIN PWR UTILS CORP | 2 | 2 | 0.04% | 0.08% | 0.12% | Q1 2020 | Q2 2020 | 2 |
OKE | ONEOK INC NEW | 2 | 2 | 0.08% | 0.08% | 0.09% | Q3 2019 | Q4 2019 | 2 |
CMPX | COMPASS THERAPEUTICS INC | 2 | 2 | 0.05% | 0.07% | 0.09% | Q3 2022 | Q4 2022 | 2 |
HTWR | HEARTWARE INTL INC | 2 | 2 | 0.04% | 0.07% | 0.09% | Q4 2013 | Q1 2014 | 2 |
MNDY | MONDAY COM LTD | 2 | 2 | 0.04% | 0.06% | 0.08% | Q1 2022 | Q2 2022 | 2 |
BRKS | AZENTA INC | 2 | 2 | 0.04% | 0.06% | 0.08% | Q4 2021 | Q1 2022 | 2 |
CMTA | CLEMENTIA PHARMACEUTIC... | 2 | 2 | 0.06% | 0.06% | 0.06% | Q3 2017 | Q4 2017 | 2 |
RINGCENTRAL INC | 2 | 2 | 0.05% | 0.06% | 0.06% | Q1 2021 | Q2 2021 | 2 | |
AMWL | AMERICAN WELL CORP | 2 | 2 | 0.04% | 0.05% | 0.06% | Q3 2020 | Q4 2020 | 2 |
RXO INC | 2 | 2 | 0.04% | 0.04% | 0.04% | Q4 2022 | Q1 2023 | 2 | |
DPZ | DOMINOS PIZZA INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q3 2020 | Q4 2020 | 2 |
IMTXW | IMMATICS N.V | 2 | 2 | 0.02% | 0.02% | 0.03% | Q3 2020 | Q4 2020 | 2 |
EQR | EQUITY RESIDENTIAL | 2 | 2 | 0.01% | 0.02% | 0.03% | Q2 2019 | Q3 2019 | 2 |
CCIPRA | CROWN CASTLE INTL CORP... | 2 | 2 | 0.01% | 0.01% | 0.01% | Q3 2019 | Q4 2019 | 2 |
TESLA MTRS INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q1 2016 | Q2 2016 | 2 | |
GOV | GOVERNMENT PPTYS INCOM... | 2 | 2 | 0.00% | 0.01% | 0.01% | Q4 2015 | Q1 2016 | 2 |
CDXS | CODEXIS INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q2 2015 | 2 |
ZFGN | ZAFGEN INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q4 2014 | Q1 2015 | 2 |
ASPEN TECHNOLOGY INC | 1 | 1 | 1.66% | 1.66% | 1.66% | Q4 2013 | Q4 2013 | 1 | |
SNDK | SANDISK CORP | 1 | 1 | 1.54% | 1.54% | 1.54% | Q1 2015 | Q1 2015 | 1 |
BIOHAVEN LTD | 1 | 1 | 1.47% | 1.47% | 1.47% | Q3 2022 | Q3 2022 | 1 | |
W | WAYFAIR INC | 1 | 1 | 0.97% | 0.97% | 0.97% | Q1 2020 | Q1 2020 | 1 |
SAGE | SAGE THERAPEUTICS INC | 1 | 1 | 0.86% | 0.86% | 0.86% | Q4 2017 | Q4 2017 | 1 |
DWSN | DAWSON GEOPHYSICAL CO | 1 | 1 | 0.68% | 0.68% | 0.68% | Q4 2013 | Q4 2013 | 1 |
TOAST INC | 1 | 1 | 0.61% | 0.61% | 0.61% | Q2 2023 | Q2 2023 | 1 | |
PS | PLURALSIGHT INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q2 2019 | Q2 2019 | 1 |
EDIT | EDITAS MEDICINE INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q4 2020 | Q4 2020 | 1 |
IMVTU | IMMUNOVANT INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q4 2019 | Q4 2019 | 1 |
NTLA | INTELLIA THERAPEUTICS INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q4 2020 | Q4 2020 | 1 |
WTRH | WAITR HLDGS INC | 1 | 1 | 0.43% | 0.43% | 0.43% | Q4 2018 | Q4 2018 | 1 |
LGVW | LONGVIEW ACQUISITION CORP | 1 | 1 | 0.34% | 0.34% | 0.34% | Q4 2020 | Q4 2020 | 1 |
HASHICORP INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2023 | Q2 2023 | 1 | |
FGEN | FIBROGEN INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q1 2023 | Q1 2023 | 1 |
JAMF | JAMF HLDG CORP | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2020 | Q3 2020 | 1 |
CLVS | CLOVIS ONCOLOGY INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q1 2014 | Q1 2014 | 1 |
ALKS | ALKERMES PLC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q2 2023 | Q2 2023 | 1 |
ARYA | ARYA SCIENCES ACQUISIT... | 1 | 1 | 0.27% | 0.27% | 0.27% | Q2 2020 | Q2 2020 | 1 |
NCINO INC | 1 | 1 | 0.27% | 0.27% | 0.27% | Q1 2022 | Q1 2022 | 1 | |
FIVN | FIVE9 INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2021 | Q3 2021 | 1 |
AESC | AES CORP | 1 | 1 | 0.26% | 0.26% | 0.26% | Q1 2023 | Q1 2023 | 1 |
FANG | DIAMONDBACK ENERGY INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q2 2023 | Q2 2023 | 1 |
ZIP | ZIPRECRUITER INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2023 | Q1 2023 | 1 |
RLAY | RELAY THERAPEUTICS INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q3 2020 | Q3 2020 | 1 |
RPHM | RENEO PHARMACEUTICALS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2023 | Q2 2023 | 1 |
HRTX | HERON THERAPEUTICS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2016 | Q4 2016 | 1 |
VSAR | VERSARTIS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2014 | Q2 2014 | 1 |
WPX | WPX ENERGY INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2014 | Q4 2014 | 1 |
ABCL | ABCELLERA BIOLOGICS INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q4 2020 | Q4 2020 | 1 |
RVMD | REVOLUTION MEDICINES INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2023 | Q2 2023 | 1 |
SGFY | SIGNIFY HEALTH INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2021 | Q1 2021 | 1 |
DVN | DEVON ENERGY CORP NEW | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2022 | Q4 2022 | 1 |
CERC | CERECOR INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2019 | Q1 2019 | 1 |
BCAB | BIOATLA INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2022 | Q3 2022 | 1 |
KNTE | KINNATE BIOPHARMA INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2020 | Q4 2020 | 1 |
SVRA | SAVARA INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2019 | Q2 2019 | 1 |
ACCURAY INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2016 | Q1 2016 | 1 | |
MAAC | MONTES ARCHIMEDES ACQU... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q2 2021 | Q2 2021 | 1 |
ONTX | ONCONOVA THERAPEUTICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2013 | Q4 2013 | 1 |
VVUS | VIVUS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2013 | Q4 2013 | 1 |
NEXTERA ENERGY INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2022 | Q4 2022 | 1 | |
ENPHASE ENERGY INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2022 | Q1 2022 | 1 | |
BXP | BOSTON PROPERTIES INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2019 | Q4 2019 | 1 |
TNDM | TANDEM DIABETES CARE INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2018 | Q1 2018 | 1 |
NEXTERA ENERGY INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2023 | Q1 2023 | 1 | |
TCF | TCF FINANCIAL CORPORAT... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q2 2020 | Q2 2020 | 1 |
OLK | OLINK HLDG AB | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2021 | Q1 2021 | 1 |
IMVTW | IMMUNOVANT INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2020 | Q1 2020 | 1 |
ARYAW | ARYA SCIENCES ACQUISIT... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2020 | Q2 2020 | 1 |
MNLO | MENLO THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2018 | Q1 2018 | 1 |
DBTX | DECIBEL THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2021 | Q1 2021 | 1 |
RPM | RPM INTL INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2021 | Q3 2021 | 1 |
INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2019 | Q4 2019 | 1 | |
FATE | FATE THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2020 | Q4 2020 | 1 |
FNB | FNB CORP PA | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2019 | Q4 2019 | 1 |
PATH | UIPATH INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2021 | Q3 2021 | 1 |
XOMETRY INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2023 | Q2 2023 | 1 | |
NERDWALLET INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q2 2023 | 1 | |
INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2019 | Q4 2019 | 1 | |
INFO | IHS MARKIT LTD | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2019 | Q4 2019 | 1 |
ESS | ESSEX PPTY TR INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2019 | Q3 2019 | 1 |
TTD | THE TRADE DESK INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
SIVB | SVB FINL GROUP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2019 | Q4 2019 | 1 |
AYX | ALTERYX INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2021 | Q2 2021 | 1 |
LMND | LEMONADE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
BRBR | BELLRING BRANDS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2020 | Q2 2020 | 1 |
PLANET LABS PBC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2021 | Q4 2021 | 1 | |
ONTF | ON24 INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2021 | Q1 2021 | 1 |
NEWR | NEW RELIC INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
GNMA | ISHARES TR | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2015 | Q3 2015 | 1 |
AMWL | AMERICAN WELL CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
CCOI | COGENT COMMUNICATIONS ... | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2020 | Q1 2020 | 1 |
ALGN | ALIGN TECHNOLOGY INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2023 | Q2 2023 | 1 |
HERCULES CAPITAL INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2019 | Q1 2019 | 1 | |
LMND | LEMONADE INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2021 | Q2 2021 | 1 |
APPN | APPIAN CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2020 | Q4 2020 | 1 |
WDC | WESTERN DIGITAL CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2019 | Q1 2019 | 1 |
OSH | OAK STR HEALTH INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2020 | Q3 2020 | 1 |
ITC | ITC HLDGS CORP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2015 | Q4 2015 | 1 |
PATTERN ENERGY GROUP INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2019 | Q1 2019 | 1 | |
AGM | FEDERAL AGRIC MTG CORP | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q3 2015 | 1 |
DLO | DLOCAL LTD | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q1 2023 | 1 |
HCN | HEALTH CARE REIT INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q3 2015 | 1 |
Download |
The securities at the top of the list , including LOWES COS INC, PALO ALTO NETWORKS INC, and ASML HOLDINGS NV, are the highest-conviction holdings of Eventide Asset Management.
The conviction is calculated by counting the number of quarters a security has been reported by Eventide Asset Management. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Eventide Asset Management owns currently or has owned in the past.